Photonic antioxidant ZnS(Cd) nanorod synthesis for drug carrier and bioimaging
Authors:
- 1 July 2013
- journal article
- Published by Taylor & Francis in Materials Technology
- Vol. 28 (4) , 228-233
Abstract
Economically viable ZnS and Cd doped ZnS nanorods were synthesised in egg albumin matrix for drug carrier and bioimaging to develop a new generation of effective drug carrier and imaging for cancer therapy. This system is capable of overcoming biophysical, biological and biomedical barriers that the physiological system encounters against conventional cancer therapies. The sulphide nanorods were formed from the hydrolysis of thiourea, where the albumin acts as a structural agent that guides in the formation of nanorods.Keywords
This publication has 18 references indexed in Scilit:
- Hot nanoparticles light up cancerNature Nanotechnology, 2010
- Development of functional gold nanorods for bioimaging and photothermal therapyJournal of Physics: Conference Series, 2010
- Preparation of low-molecular-weight chitosan derivative zinc complexes and their effect on the growth of liver cancer cells in vitroPure and Applied Chemistry, 2009
- Coordination Dynamics of Zinc in ProteinsChemical Reviews, 2009
- CdSe/CdS/ZnS Double Shell Nanorods with High Photoluminescence Efficiency and Their Exploitation As Biolabeling ProbesJournal of the American Chemical Society, 2009
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticlesJournal of Controlled Release, 2008
- Mechanism and Modeling of Nanorod Formation from NanodotsLangmuir, 2007
- Time-selective Hydrothermal Synthesis of SnS Nanorods and Nanoparticles by Thiourea HydrolysisChemistry Letters, 2004
- Nanoparticles in cancer therapy and diagnosisAdvanced Drug Delivery Reviews, 2002
- Unique features of albuminCritical Care Medicine, 1989